Test ID BLOD1201 Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Serum
Useful For
Diagnosis of a neuromyelitis optica spectrum disorder (NMOSD)
Diagnosis of autoimmune AQP4 channelopathy
Diagnosis of neuromyelitis optica (NMO)
Distinguishing NMOSD from multiple sclerosis early in the course of disease
Specimen Type
SerumOrdering Guidance
Specimen Required
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 3 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Specimen Minimum Volume
2 mL
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Day(s) Performed
Monday, Tuesday, Thursday
Report Available
5 to 8 daysMethod Name
Flow Cytometry
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
86053
86053-titer (if appropriate)
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
NMOTS | NMO/AQP4 FACS Titer, S | No | No |
Testing Algorithm
When the results of this assay require further evaluation, NMOTS / Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Titer Assay, Serum will be performed at an additional charge.
Reporting Name
NMO/AQP4 FACS, SReference Values
Negative
Secondary ID
38324Forms
If not ordering electronically, complete, print, and send Neurology Specialty Testing Client Test Request (T732) with the specimen.
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.SANFORD INTERFACE BUILD INFORMATION
Result Code | Result Code Description |
---|---|
13317 | NMO/AQP4-IgG |